Free access
Review
Issue
Vet. Res.
Volume 40, Number 3, May-June 2009
Number of page(s) 30
DOI http://dx.doi.org/10.1051/vetres:2008051
Published online 02 December 2008
How to cite this article Vet. Res. (2009) 40:13
References of  Vet. Res. (2009) 40:13
  1. Aggarwal N., Zhang Z., Cox S., Statham R., Alexandersen S., Kitching R.P., Barnett P.V., Experimental studies with foot-and-mouth disease virus, strain O, responsible for the 2001 epidemic in the United Kingdom, Vaccine (2002) 20:2508–2515 [CrossRef] [PubMed].
  2. Alexandersen S., Zhang Z., Donaldson A.I., Garland A.J.M., The pathogenesis and diagnosis of foot-and-mouth disease, J. Comp. Pathol. (2003) 129:1–36 [CrossRef] [PubMed].
  3. Arnold M.E., Paton D.J., Ryan E., Cox S.J., Wilesmith J.W., Modeling studies to estimate the prevalence of foot-and-mouth disease carriers after reactive vaccination, Proc. R. Soc. B (2008) 275:107–115 [CrossRef].
  4. Barnett P.V., Pullen L., Williams L., Doel T.R., International bank for foot-and-mouth disease vaccine: assessment of Montanide ISA 25 and ISA 206, two commercially available oil adjuvants, Vaccine (1996) 14:1187–1198 [CrossRef] [PubMed].
  5. Barnett P.V., Cox S.J., The role of small ruminants in the epidemiology and transmission of foot-andmouth disease, Vet. J. (1999) 158:6–13 [CrossRef] [PubMed].
  6. Barnett P., Garland A.J.M., Kitching R.P., Schermbrucker C.G., Aspects of emergency vaccination against foot-and-mouth disease, Comp. Immunol. Microbiol. Infect. Dis. (2002) 25:345–364 [CrossRef] [PubMed].
  7. Barnett P.V., Cox S.J., Aggarwal N., Gerber H., McCullough K.C., Further studies on the early protective responses of pigs following immunization with high potency foot-and-mouth disease vaccine, Vaccine (2002) 20:3197–3208 [CrossRef] [PubMed].
  8. Barnett P.V., Statham R.J., Stratified and cryogenically stored (SACS) vaccines, a new concept in emergency foot-and-mouth disease vaccine formulation and storage, Vaccine (2002) 20:2060–2064 [PubMed].
  9. Barnett P.V., Carabin H., A review of emergency foot-and-mouth disease (FMD) vaccines, Vaccine (2002) 20:1505–1514 [CrossRef] [PubMed].
  10. Barnett P.V., Keel P., Reid S., Armstrong R.M., Statham R.J., Voyce C., et al., Evidence that high potency foot-and-mouth disease vaccine inhibits local virus replication and prevents the `carrier' state in sheep, Vaccine (2004) 22:1221–1232 [CrossRef] [PubMed].
  11. Barteling S.J., Vreeswijk J., Developments in foot-and-mouth vaccines. Review, Vaccine (1991) 9:75–88 [CrossRef] [PubMed].
  12. Belsham G.J., Distinctive features of foot-andmouth disease virus, a member of the picornavirus family; aspects of virus protein synthesis, protein processing and structure, Prog. Biophys. Mol. Biol. (1993) 60:241–260 [CrossRef] [PubMed].
  13. Bouma A., Dekker A., de Jong M.C.M., No foot-and-mouth disease virus transmission between individually housed calves, Vet. Microbiol. (2004) 98:29–36 [CrossRef] [PubMed].
  14. Brehm K.E., Kumar N., Thulke H.-H., Haas B., High potency vaccines induce protection against heterologous challenge with foot-and-mouth disease virus, Vaccine (2008) 26:1681–1687 [CrossRef] [PubMed].
  15. Brocchi E., Bergmann I.E., Dekker A., Paton D.J., Sammin D.J., Greiner M., et al., Comparative evaluation of six ELISAs for the detection of antibodies to the non-structural proteins of foot-andmouth disease virus, Vaccine (2006) 24:6966–6979 [CrossRef] [PubMed].
  16. Callis J.J., McKercher P.D., Graves J.H., Footand-mouth disease – a review, J. Am. Vet. Med. Assoc. (1968) 153:1798–1802 [PubMed].
  17. Casas-Olascoaga R., The history of foot-andmouth disease control in South America, in: Dodet B., Vicari M. (Eds.), Foot-and- mouth disease: control strategies, Elsevier, Paris, 2003, pp. 55–72.
  18. Coetzer J.A.W., Thomsen G.R., Tustin R.C., Kriek N.P.J., Foot-and-mouth disease, in: Coetzer J.A.W., Thomsen G.R, Tustin R.C., Kriek N.P.J. (Eds.), Infectious diseases of livestock with special reference to Southern Africa, Oxford University Press, Cape Town, 1994, pp. 825–852.
  19. Cox S.J., Barnett P.V., Dani P., Salt J.S., Emergency vaccination of sheep against foot-and-mouth disease: protection against disease and reduction in contact transmission, Vaccine (1999) 17:1858–1868 [CrossRef] [PubMed].
  20. Cox S.J., Aggarwal N., Statham R.J., Barnett P.V., Longevity of antibody and cytokine responses following vaccination with high potency emergency FMD vaccines, Vaccine (2003) 21:1336–1347 [CrossRef] [PubMed].
  21. Cox S.J., Voyce C., Parida S., Reid S.M., Hamblin P.A., Paton D.J., Barnett P.V., Protection against direct contact challenge following emergency FMD vaccination of cattle and the effect on virus excretion from the oropharynx, Vaccine (2005) 23:1106–1113 [CrossRef] [PubMed].
  22. Cox S.J., Voyce C., Parida S., Reid S.M., Hamblin P.A., Hutchings G., et al., Effect of emergency FMD vaccine antigen payload on protection, sub-clinical infection and persistence following direct contact challenge of cattle, Vaccine (2006) 24:3184–3190 [CrossRef] [PubMed].
  23. Cox S.J., Parida S., Voyce C., Reid S.M., Hamblin P.A., Hutchings G., et al., Further evaluation of higher potency vaccines for early protection of cattle against FMDV direct contact challenge, Vaccine (2007) 25:40–50.
  24. De Clercq K., Goris N., Barnett P.V., Mackay D.K., FMD Vaccines: Reflections of quality aspects for applicability in European disease control policy, Transbound. Emerg. Dis. (2008) 55:35–45.
  25. Doel T.R., Williams L., Barnett P.V., Emergency vaccination against foot-and-mouth disease: rate of development of immunity and its implication for the carrier state, Vaccine (1994) 12:592–600 [CrossRef] [PubMed].
  26. Doel T.R., Natural and vaccine-induced immunity to foot-and-mouth disease: the prospects for improved vaccines, Rev. Sci. Tech. Off. Int. Epizoot. (1996) 15:883–911.
  27. Doel T.R., Optimisation of the immune response to foot-and-mouth disease vaccines, Vaccine (1999) 17:1767–1771 [CrossRef] [PubMed].
  28. Doel T.R., FMD vaccines, Virus Res. (2003) 91:81–99 [CrossRef] [PubMed].
  29. Donaldson A.I., Kitching R.P., Transmission of foot-and-mouth disease by vaccinated cattle following natural challenge, Res. Vet. Sci. (1989) 46:9–14 [PubMed].
  30. Eblé P.L., Bouma A., de Bruin M.G.M., van Hemert-Kluitenberg F., Van Oirschot J.T., Dekker A., Vaccination of pigs two weeks before infection significantly reduces transmission of foot-and-mouth disease virus, Vaccine (2004) 22:1372–1374 [CrossRef] [PubMed].
  31. Eblé P.L., de Bruin M.G.M., Bouma A., van Hemert-Kluitenberg F., Van Oirschot J.T., Dekker A., Comparison of immune responses after intra-typic heterologous and homologous vaccination against foot-and-mouth disease virus in pigs, Vaccine (2006) 24:1274–1281 [CrossRef] [PubMed].
  32. Eblé P.L., Bouma A., Weerdmeester J.A., Stegeman J.A., Dekker A., Serological and mucosal immune responses after vaccination and infection with FMDV in pigs, Vaccine (2007) 25:1043–1054 [CrossRef] [PubMed].
  33. Eblé P.L., de Koeijer A.A., de Jong M.C.M., Engel B., Dekker A., A meta-analysis quantifying transmission parameters of FMDV strain O Taiwan among non-vaccinated and vaccinated pigs, Prev. Vet. Med. (2008) 83:98–106 [CrossRef] [PubMed].
  34. European Directorate for the Quality of Medicines, European Pharmacopoeia, 6th ed., Vol. 6.0-6.2, Strasbourg, 2008.
  35. Fracastorius H., De contagione et contagiosis morbis et curatione, Book 1, Chap. 12, Venecia, 1546.
  36. Gibson C.F., Donaldson A.I., Ferris N.P., Responses of sheep vaccinated with large doses of vaccine to challenge by airborne foot-and-mouth disease virus, Vaccine (1984) 2:157–161 [CrossRef] [PubMed].
  37. Gleeson G.L., Samuel A.R., Knowles N.J., Epidemiology of foot-and-mouth disease in Southeast Asia, in: Dodet B., Vicari M. (Eds.), Foot-andmouth disease: control strategies, Elsevier, Paris, 2003, pp. 85–96.
  38. Graves J.H., McKercher P.D., Farris H.E. Jr., Cowan K.M., Early responses of cattle and swine to inactivated foot-and-mouth disease vaccine, Res. Vet. Sci. (1968) 9:35–40 [PubMed].
  39. Hunter P., The performance of Southern African Territories serotypes of foot-and-mouth disease antigen in oil-adjuvanted vaccines, Rev. Sci. Tech. Off. Int. Epizoot. (1996) 13:913–922.
  40. Leforban Y., Gerbier G., Recent history and epidemiology of foot-and-mouth disease in Europe, in: Dodet B., Vicari M. (Eds.), Foot-and-mouth disease: control strategies, Elsevier, Paris, 2003, pp. 153–171.
  41. Loeffler F., Frosch P., Summarischer Bericht über die Ergebnisse der Untersuchungen der Kommoission zur Erforchung der Maul-und-Klamenseuche, Zentralbl. Bakteriol. Parasitenkd. Infektionskr. Hyg. (1897) 22:257–259.
  42. McVicar J.W., Sutmoller P., Growth of foot-andmouth disease virus in the upper respiratory tract of non-immunized, vaccinated and recovered cattle after intranasal inoculation, J. Hyg. (Lond.) (1976) 76:467–481 [PubMed].
  43. Murray J.G., Butler R., Svarcas P.L., Foot-andmouth disease emergency preparedness strategy and evaluation: the Australian perspective, in: Dodet B., Vicari M. (Eds.), Foot-and-mouth disease: control strategies, Elsevier, Paris, 2003, pp. 105–113.
  44. Office International des Epizooties (World Organisation for Animal Health), Foot-and-mouth disease, in: Terrestrial Animal Health Code, 15th ed., OIE, Paris, France, 2006, Chap. 2.2.10.
  45. Orsel K., Dekker A., Bouma A., Stegeman J.A., de Jong M.C.M., Vaccination against foot-and-mouth disease reduces virus transmission in groups of calves, Vaccine (2005) 23:4887–4894 [CrossRef] [PubMed].
  46. Orsel K., de Jong M.C.M., Bouma A., Stegeman J.A., Dekker A., Foot-and-mouth disease virus transmission among vaccinated pigs after exposure to virus shedding pigs, Vaccine (2007) 25:6381–6391 [CrossRef] [PubMed].
  47. Orsel K., de Jong M.C.M., Bouma A., Stegeman J.A., Dekker A., The effect of vaccination on foot-andmouth disease virus transmission among dairy cows, Vaccine (2007) 25:327–335 [CrossRef] [PubMed].
  48. Orsel K., Dekker A., Bouma A., Stegeman J.A., de Jong M.C.M., Quantification of foot-and-mouth disease virus excretion and transmission within groups of lambs with and without vaccination, Vaccine (2007) 25:2673–2679 [CrossRef] [PubMed].
  49. Parida S., Cox S.J., Reid S.M., Hamblin P., Barnett P.V., Inoue T., et al., The application of new techniques to the improved detection of persistently infected cattle after vaccination and contact exposure to foot-and-mouth disease, Vaccine (2005) 23:5186–5195 [CrossRef] [PubMed].
  50. Parida S., Anderson J., Cox S.J., Barnett P.V., Paton D.J., Secretory IgA as an indicator of oropharyngeal foot-and-mouth disease virus replication and as a tool for post vaccination surveillance, Vaccine (2006) 24:1107–1116 [CrossRef] [PubMed].
  51. Parida S., Fleming L., Oh Y., Mahapatra M., Hamblin P., Gloster J., et al., Reduction of foot-andmouth disease (FMD) virus load in nasal excretions, saliva and exhaled air of vaccinated pigs following direct contact challenge, Vaccine (2007) 25:7806–7817 [CrossRef] [PubMed].
  52. Parida S., Fleming L., Oh Y., Mahapatra M., Hamblin P., Gloster J., Paton D.J., Emergency vaccination of sheep against foot-and-mouth disease: significance and detection of subsequent sub-clinical infection, Vaccine (2008) 26:3469–3479 [CrossRef] [PubMed].
  53. Paton D.J., Valarcher J.-F., Bergmann I., Matlho O.G., Zakharov V.M., Palma E.L., Thomson G.R., Selection of foot-and-mouth disease vaccine strains – a review, Rev. Sci. Tech. Off. Int. Epizoot. (2005) 24:981–993.
  54. Paton D.J., de Clercq K., Greiner M., Dekker A., Brocchi E., Bergmann I., et al., Application of non-structural protein antibody tests in substantiating freedom from foot-and-mouth disease virus infection after emergency vaccination of cattle, Vaccine (2006) 24:6503–6512 [CrossRef] [PubMed].
  55. Pay T.W.F., Hingley P.J., The use of serum neutralizing antibody assay for the determination of the potency of foot-and-mouth disease vaccines in cattle, Dev. Biol. Stand. (1986) 64:153–161 [PubMed].
  56. Rweyemamu M., Roeder P., Mackay D., Sumption K., Brownlie J., Leforban Y., Planning for the progressive control of foot-and-mouth disease worldwide, Transbound. Emerg. Dis. (2008) 55:73–87.
  57. Salt J.S., Barnett P.V., Dani P., Williams L., Emergency vaccination of pigs against foot-and-mouth disease: protection against disease and reduction in contact transmission, Vaccine (1998) 16:746–754 [CrossRef] [PubMed].
  58. Sellers R.F., Parker J., Air-borne excretion of foot-and-mouth disease virus, J. Hyg. (Lond.) (1969) 67:671–677 [PubMed].
  59. Sellers R.F., Herniman K.A.J., Early protection of pigs against foot-and-mouth disease, Br. Vet. J. (1974) 130:440–445 [PubMed].
  60. Sellers R.F., Herniman K.A.J., Gumm I.D., The airborne dispersal of foot-and-mouth disease virus from vaccinated and recovered pigs, cattle and sheep after exposure to infection, Res. Vet. Sci. (1977) 23:70–75 [PubMed].
  61. Sobrino F., Saiz M., Jimenez-Clavero M.A., Nunez J.J., Rosas M.F., Baranowski E., Ley V., Footand-mouth disease: a long known virus, but a current threat, Vet. Res. (2001) 32:1–30 [CrossRef] [PubMed] [EDP Sciences].
  62. Sutmoller P., McVicar J.W., Cottral G.E., The epizootiological importance of foot-and-mouth disease carriers. 1. Experimentally produced foot-and-mouth disease carriers in susceptible and immune cattle, Arch. Gesamte Virusforsch. (1968) 23:227–235 [CrossRef] [PubMed].
  63. Sutmoller P., Cottral G.E., McVicar J.W., A review of the carrier state in foot-and-mouth disease, Proc. Annu. Meet. US Anim. Health Assoc. (1967) 71:386-395.
  64. Sutmoller P., Barteling S.S., Casas Olascoaga R., Sumption K.J., Control and eradication of foot-and mouth disease, Virus Res. (2003) 91:101–144 [CrossRef] [PubMed].
  65. Thomson G.R., Vosloo W., Bastos A.D.S., The epidemiology and control of foot-and-mouth disease in sub-Saharan Africa, in: Dodet B., Vicari M. (Eds.), Foot-and- mouth disease: control strategies, Elsevier, Paris, 2003, pp. 125–134.